Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Polaryx Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	5.75	4.62	0
Cash & Cash Equivalents	5.75	4.62	0
Cash Growth	-	230950.00%	-
Other Current Assets	0.24	0.38	2.31
Total Current Assets	5.98	5	2.32
Total Assets	-	5	2.32
Accounts Payable	-	0.07	0.47
Current Debt	-	0.13	0.48
Other Current Liabilities	0.68	0.09	0.09
Total Current Liabilities	0.68	0.29	1.04
Total Liabilities	-	0.29	1.04
Total Debt	0.18	0.13	0.48
Debt Growth	-	-72.80%	-
Retained Earnings	-	-90.65	-60.29
Shareholders' Equity	-98.14	4.71	1.28
Net Cash (Debt)	5.57	4.49	-0.48
Working Capital	5.3	4.71	1.28

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).